AU4504000A
(en)
*
|
1993-04-27 |
2000-09-07 |
Sepracor, Inc. |
Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
|
SE9301489D0
(sv)
|
1993-04-30 |
1993-04-30 |
Ab Astra |
Veterinary composition
|
US6875872B1
(en)
|
1993-05-28 |
2005-04-05 |
Astrazeneca |
Compounds
|
DE4324014C2
(de)
*
|
1993-07-17 |
1995-06-08 |
Byk Gulden Lomberg Chem Fab |
Verfahren zur Herstellung einer in Wasser rekonstituierbaren Zubereitung
|
TW280770B
(fr)
|
1993-10-15 |
1996-07-11 |
Takeda Pharm Industry Co Ltd |
|
DK0723436T3
(da)
*
|
1994-07-08 |
2001-11-26 |
Astrazeneca Ab |
Tabletteret flerenhedsdoseringsform
|
SE9402431D0
(sv)
*
|
1994-07-08 |
1994-07-08 |
Astra Ab |
New tablet formulation
|
ES2094694B1
(es)
*
|
1995-02-01 |
1997-12-16 |
Esteve Quimica Sa |
Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
|
SE9500478D0
(sv)
*
|
1995-02-09 |
1995-02-09 |
Astra Ab |
New pharmaceutical formulation and process
|
US5945124A
(en)
*
|
1995-07-05 |
1999-08-31 |
Byk Gulden Chemische Fabrik Gmbh |
Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
|
ES2236628T3
(es)
*
|
1995-09-21 |
2005-07-16 |
Pharma Pass Ii Llc |
Composicion farmaceutica que contiene un omeprazol labil de acido, y procedimiento para su preparacion.
|
SI9700186B
(sl)
*
|
1997-07-14 |
2006-10-31 |
Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. |
Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
|
ES2137862B1
(es)
*
|
1997-07-31 |
2000-09-16 |
Intexim S A |
Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
|
ATE260090T1
(de)
*
|
1997-12-08 |
2004-03-15 |
Altana Pharma Ag |
Neue suppositoriumsform mit säureempfindliche wirkstoffe
|
DK173431B1
(da)
|
1998-03-20 |
2000-10-23 |
Gea Farmaceutisk Fabrik As |
Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs
|
CN1141097C
(zh)
*
|
1998-04-20 |
2004-03-10 |
卫材株式会社 |
含有稳定化的苯并咪唑类化合物的组合物
|
JP4127740B2
(ja)
*
|
1998-04-20 |
2008-07-30 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
安定化したベンズイミダゾール系化合物含有組成物
|
DK1736144T3
(en)
|
1998-05-18 |
2015-12-07 |
Takeda Pharmaceutical |
Orally disintegrating tablets.
|
ZA9810765B
(en)
*
|
1998-05-28 |
1999-08-06 |
Ranbaxy Lab Ltd |
Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole.
|
ES2262335T3
(es)
|
1998-08-12 |
2006-11-16 |
Altana Pharma Ag |
Forma de administracion oral para piridin-2-ilmetilsulfinil-1h-bencimidazoles.
|
DE19843413C1
(de)
*
|
1998-08-18 |
2000-03-30 |
Byk Gulden Lomberg Chem Fab |
Neue Salzform von Pantoprazol
|
YU86001A
(sh)
|
1999-06-07 |
2004-07-15 |
Altana Pharma Ag. |
Novi preparat i oblik, u kojem se daje lek, koji sadrži aktivno jedinjenje labilno prema kiselini
|
ES2168043B1
(es)
*
|
1999-09-13 |
2003-04-01 |
Esteve Labor Dr |
Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
|
DE60036014T2
(de)
|
1999-10-20 |
2008-04-30 |
Eisai R&D Management Co., Ltd. |
Methode zur stabilisierung von benzimidazol-verbindungen
|
DE19959419A1
(de)
|
1999-12-09 |
2001-06-21 |
Ratiopharm Gmbh |
Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
|
ES2244167T3
(es)
*
|
1999-12-16 |
2005-12-01 |
Laboratorio Medinfar-Produtos Farmaceuticos, S.A. |
Nuevas preparaciones farmaceuticas multiunitarias estables que contienen bencimidazoles sustituidos.
|
SK287684B6
(sk)
*
|
1999-12-20 |
2011-06-06 |
Schering Corporation |
Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním
|
AU2276801A
(en)
|
1999-12-20 |
2001-07-03 |
Schering Corporation |
Extended release oral dosage composition
|
US6544556B1
(en)
|
2000-09-11 |
2003-04-08 |
Andrx Corporation |
Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
|
WO2002045692A1
(fr)
*
|
2000-12-07 |
2002-06-13 |
Altana Pharma Ag |
Preparation pharmaceutique sous forme de suspension contenant un ingredient actif labile en milieu acide
|
ES2311073T3
(es)
|
2001-09-28 |
2009-02-01 |
Mcneil-Ppc, Inc. |
Forma de dosificacion que tiene un nucleo interno y un revestimiento externo.
|
US20050163846A1
(en)
*
|
2001-11-21 |
2005-07-28 |
Eisai Co., Ltd. |
Preparation composition containing acid-unstable physiologically active compound, and process for producing same
|
US20050220870A1
(en)
*
|
2003-02-20 |
2005-10-06 |
Bonnie Hepburn |
Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
|
WO2004080439A1
(fr)
*
|
2003-03-12 |
2004-09-23 |
Takeda Pharmaceutical Company Limited |
Composition de medicament comportant un principe actif adhere en concentration elevee a un noyau spherique
|
WO2004098573A1
(fr)
*
|
2003-05-08 |
2004-11-18 |
Natco Pharma Limited |
Composition pharmaceutique amelioree et stable contenant des benzimidazoles substitues et son procede de preparation
|
CL2004000983A1
(es)
*
|
2003-05-08 |
2005-03-04 |
Altana Pharma Ag |
Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
|
PE20050150A1
(es)
*
|
2003-05-08 |
2005-03-22 |
Altana Pharma Ag |
Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
|
US20050042277A1
(en)
*
|
2003-07-17 |
2005-02-24 |
Irukulla Srinivas |
Pharmaceutical compositions having a swellable coating
|
CA2532310A1
(fr)
*
|
2003-07-17 |
2005-02-03 |
Dr. Reddy's Laboratories, Inc. |
Compositions pharmaceutiques a revetement gonflant
|
US20050147663A1
(en)
*
|
2003-07-17 |
2005-07-07 |
Mohan Mailatur S. |
Method of treatment for improved bioavailability
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
AU2004271747A1
(en)
*
|
2003-09-18 |
2005-03-24 |
Altana Pharma Ag |
Use of known active ingredients as radical scavengers
|
TWI372066B
(en)
|
2003-10-01 |
2012-09-11 |
Wyeth Corp |
Pantoprazole multiparticulate formulations
|
WO2005034924A1
(fr)
*
|
2003-10-14 |
2005-04-21 |
Natco Pharma Limited |
Pastilles a enrobage enterique comprenant de l'esomeprazole, capsule de gelatine dure renfermant celles-ci et procede de preparation associe
|
US20050175689A1
(en)
*
|
2003-10-27 |
2005-08-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
Coated fine particles containing drug for intrabuccally fast disintegrating tablet
|
EP1677770A2
(fr)
*
|
2003-10-31 |
2006-07-12 |
Dexcel Ltd. |
Formulation stable contenant du lansoprazole
|
WO2005046634A2
(fr)
*
|
2003-11-14 |
2005-05-26 |
Siegfried Generics International Ag |
Forme galenique resistant au suc gastrique
|
HU227317B1
(en)
*
|
2003-11-25 |
2011-03-28 |
Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag |
Enteric coated tablet containing pantoprazole
|
US20050244490A1
(en)
*
|
2003-12-09 |
2005-11-03 |
Michael Otto |
Dosing methods for beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine antiviral therapy
|
EP1718303A4
(fr)
*
|
2004-02-10 |
2010-09-01 |
Santarus Inc |
Combinaison d'un inhibiteur de la pompe a protons, d'un tampon et d'un medicament anti-inflammatoire non steroidien
|
RU2359670C2
(ru)
*
|
2004-03-25 |
2009-06-27 |
Астеллас Фарма Инк. |
Композиция солифенацина или его соли для использования в твердом препарате
|
BRPI0509135A
(pt)
*
|
2004-03-26 |
2007-08-28 |
Eisai R&D Man Co Ltd |
composição farmacêutica de liberação controlada e método para produzir a mesma
|
RS52233B
(en)
|
2004-05-07 |
2012-10-31 |
Nycomed Gmbh |
THE PHARMACEUTICAL DOSAGE FORM CONTAINING GRANULES AND ITS PRODUCTION PROCEDURE
|
US8815916B2
(en)
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US20050281876A1
(en)
*
|
2004-06-18 |
2005-12-22 |
Shun-Por Li |
Solid dosage form for acid-labile active ingredient
|
US20060024362A1
(en)
|
2004-07-29 |
2006-02-02 |
Pawan Seth |
Composition comprising a benzimidazole and process for its manufacture
|
DE102004042139B4
(de)
*
|
2004-08-31 |
2009-06-10 |
Aristocon Verwaltungs- Gmbh |
Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
|
EP1830822A1
(fr)
*
|
2004-12-24 |
2007-09-12 |
LEK Pharmaceuticals D.D. |
Composition pharmaceutique stable comprenant un substance active sous la forme d'une solution solide
|
WO2006070735A1
(fr)
*
|
2004-12-27 |
2006-07-06 |
Astellas Pharma Inc. |
Préparation pharmaceutique granulaire stable de solifénacine ou de son sel
|
US20090208575A1
(en)
*
|
2005-01-03 |
2009-08-20 |
Lupin Limited |
Pharmaceutical Composition Of Acid Labile Substances
|
US8673352B2
(en)
|
2005-04-15 |
2014-03-18 |
Mcneil-Ppc, Inc. |
Modified release dosage form
|
CA2608444A1
(fr)
*
|
2005-05-13 |
2007-03-15 |
Combino Pharm, S.L. |
Formulations contenant de l acide libre de pantoprazole et les sels de ce dernier
|
US7815939B2
(en)
*
|
2005-07-20 |
2010-10-19 |
Astellas Pharma Inc. |
Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms
|
EP1747776A1
(fr)
*
|
2005-07-29 |
2007-01-31 |
KRKA, tovarna zdravil, d.d., Novo mesto |
Composition pharmaceutique comprenant du pantoprazole granulaire
|
JPWO2007037259A1
(ja)
*
|
2005-09-29 |
2009-04-09 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
生体内での崩壊性を向上させたパルス製剤
|
US7598273B2
(en)
*
|
2005-10-06 |
2009-10-06 |
Auspex Pharmaceuticals, Inc |
Inhibitors of the gastric H+, K+-ATPase with enhanced therapeutic properties
|
US8486450B2
(en)
|
2005-12-28 |
2013-07-16 |
Takeda Pharmaceutical Company Limited |
Method of producing solid preparation disintegrating in the oral cavity
|
WO2007080601A1
(fr)
|
2006-01-16 |
2007-07-19 |
Jubilant Organosys Limited |
Formulation pharmaceutique stable d'un compose labile a base d'acide et son procede de preparation
|
JP2009538901A
(ja)
*
|
2006-06-01 |
2009-11-12 |
デクセル ファーマ テクノロジーズ エルティーディー. |
複式ユニット製薬的製剤
|
EP2068841B1
(fr)
|
2006-10-05 |
2018-09-26 |
Santarus, Inc. |
Nouvelles formulations pour une libération immédiate d'inhibiteurs de pompe à protons et procédés d'utilisation de ces formulations
|
US20100105738A1
(en)
*
|
2006-10-06 |
2010-04-29 |
Mitsuru Mizuno |
Extended release formulations of a proton pump inhibitor
|
EP2486910A3
(fr)
|
2006-10-27 |
2012-08-22 |
The Curators Of The University Of Missouri |
Appareil comprenant plusieurs chambres et une tête de distribution
|
PL2124884T3
(pl)
|
2006-12-22 |
2020-01-31 |
Ironwood Pharmaceuticals, Inc. |
Metody i kompozycje do leczenia zaburzeń przełyku
|
US8821924B2
(en)
|
2007-09-14 |
2014-09-02 |
Wockhardt Ltd. |
Rhein or diacerein compositions
|
WO2012027331A1
(fr)
|
2010-08-27 |
2012-03-01 |
Ironwood Pharmaceuticals, Inc. |
Compositions et procédés pour traiter ou prévenir un syndrome métabolique et des maladies et troubles associés
|
DE102010052847A1
(de)
*
|
2010-11-29 |
2012-05-31 |
Temmler Werke Gmbh |
Verfahren zur Herstellung einer PPI-haltigen pharmazeutischen Zubereitung
|
EP3991719A1
(fr)
|
2013-01-15 |
2022-05-04 |
Ironwood Pharmaceuticals, Inc. |
Forme posologique orale à libération prolongée à rétention gastrique d'un agent séquestrant d'acide biliaire
|
US20180015118A1
(en)
|
2015-02-03 |
2018-01-18 |
Ironwood Pharmaceuticals, Inc. |
Methods of treating upper gastrointestinal disorders in ppi refractory gerd
|
WO2016174664A1
(fr)
|
2015-04-29 |
2016-11-03 |
Dexcel Pharma Technologies Ltd. |
Compositions à désintégration par voie orale
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
CN108065443B
(zh)
*
|
2017-12-30 |
2020-02-28 |
厦门金达威维生素有限公司 |
斥水型双包被微胶囊及其制备方法
|
CN114569579B
(zh)
|
2020-12-02 |
2023-10-31 |
丽珠医药集团股份有限公司 |
肠溶微丸、其制备方法和包含它的制剂
|
WO2024075017A1
(fr)
|
2022-10-04 |
2024-04-11 |
Zabirnyk Arsenii |
Inhibition de calcification de valve aortique
|